Proteomics analysis of tissues from patients with pancreatic ductal adenocarcinoma identified DSG2 as among the top four candidate up-regulated proteins, and serum validation showed significant elevation of DSG2 levels in cancer patient samples [41]. This evidence concerns the gene DSG2 and pancreatic ductal adenocarcinoma.